Lomon So

1.6k total citations
16 papers, 1.0k citations indexed

About

Lomon So is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lomon So has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Oncology. Recurrent topics in Lomon So's work include PI3K/AKT/mTOR signaling in cancer (6 papers), interferon and immune responses (4 papers) and Viral Infections and Immunology Research (3 papers). Lomon So is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), interferon and immune responses (4 papers) and Viral Infections and Immunology Research (3 papers). Lomon So collaborates with scholars based in United States, United Kingdom and South Korea. Lomon So's co-authors include Sharmila Mallya, Ram Savan, Matthew R. Janes, Jose J. Limon, Adriana Forero, Pingda Ren, Michael Martin, Christian Rommel, Snehal Ozarkar and Michael Gale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lomon So

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lomon So United States 13 600 442 198 156 107 16 1.0k
Markus Duechler Poland 17 640 1.1× 187 0.4× 178 0.9× 156 1.0× 89 0.8× 29 981
Katja Fiedler Germany 12 584 1.0× 287 0.6× 127 0.6× 76 0.5× 57 0.5× 16 978
Alejo A. Morales United States 13 485 0.8× 332 0.8× 188 0.9× 70 0.4× 143 1.3× 33 888
Thomas Perlot Austria 13 583 1.0× 781 1.8× 138 0.7× 50 0.3× 60 0.6× 14 1.3k
Corinne Hiéblot France 18 496 0.8× 341 0.8× 117 0.6× 106 0.7× 64 0.6× 25 1.1k
Ai Kotani Japan 19 541 0.9× 347 0.8× 177 0.9× 72 0.5× 70 0.7× 51 1.0k
Kentaro Bandobashi Japan 16 520 0.9× 187 0.4× 419 2.1× 65 0.4× 150 1.4× 33 1.1k
Tomoko Hata Japan 22 387 0.6× 681 1.5× 156 0.8× 148 0.9× 326 3.0× 96 1.5k
Patrizia Mella Italy 18 238 0.4× 553 1.3× 281 1.4× 177 1.1× 199 1.9× 29 1.2k
Shigeto Kawai Japan 14 339 0.6× 281 0.6× 188 0.9× 48 0.3× 152 1.4× 28 837

Countries citing papers authored by Lomon So

Since Specialization
Citations

This map shows the geographic impact of Lomon So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lomon So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lomon So more than expected).

Fields of papers citing papers by Lomon So

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lomon So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lomon So. The network helps show where Lomon So may publish in the future.

Co-authorship network of co-authors of Lomon So

This figure shows the co-authorship network connecting the top 25 collaborators of Lomon So. A scholar is included among the top collaborators of Lomon So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lomon So. Lomon So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chong, Zhenlu, Sharmila Nair, Lomon So, et al.. (2024). Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production. Immunity. 57(3). 446–461.e7. 13 indexed citations
2.
So, Lomon, Thomas S. Ebert, Veit Hornung, et al.. (2024). The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation. Immunity. 57(8). 1812–1827.e7. 4 indexed citations
3.
So, Lomon, Kazushige Obata‐Ninomiya, Alex Hu, et al.. (2022). Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis. The Journal of Experimental Medicine. 220(3). 18 indexed citations
4.
Allenspach, Eric J., Frank Soveg, Laura S. Finn, et al.. (2021). Germline SAMD9L truncation variants trigger global translational repression. The Journal of Experimental Medicine. 218(5). 25 indexed citations
5.
Schwerk, Johannes, Frank Soveg, Kerri R. Thomas, et al.. (2019). RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions. Nature Immunology. 20(12). 1610–1620. 91 indexed citations
6.
Forero, Adriana, Snehal Ozarkar, Hongchuan Li, et al.. (2019). Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons. Immunity. 51(3). 451–464.e6. 176 indexed citations
7.
Forero, Adriana, Lomon So, & Ram Savan. (2017). Re-evaluating Strategies to Define the Immunoregulatory Roles of miRNAs. Trends in Immunology. 38(8). 558–566. 13 indexed citations
8.
So, Lomon, Jong‐Dae Lee, Sharmila Mallya, et al.. (2016). The 4E-BP–eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes. Science Signaling. 9(430). ra57–ra57. 54 indexed citations
9.
Yea, Sung Su, Lomon So, Sharmila Mallya, et al.. (2014). Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function. PLoS ONE. 9(6). e99486–e99486. 11 indexed citations
10.
Mallya, Sharmila, et al.. (2014). Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1. PLoS ONE. 9(2). e88865–e88865. 33 indexed citations
11.
Limon, Jose J., Lomon So, Stefan Jellbauer, et al.. (2014). mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. Proceedings of the National Academy of Sciences. 111(47). E5076–85. 52 indexed citations
12.
Roy, Saurabh G., Michael Stevens, Lomon So, & Aimee L. Edinger. (2013). Reciprocal effects ofrab7deletion in activated and neglected T cells. Autophagy. 9(7). 1009–1023. 31 indexed citations
13.
So, Lomon, Sung Su Yea, Jean Oak, et al.. (2012). Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function*. Journal of Biological Chemistry. 288(8). 5718–5731. 59 indexed citations
14.
So, Lomon, et al.. (2012). PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochemical Journal. 442(3). 465–481. 181 indexed citations
15.
Janes, Matthew R., Jose J. Limon, Lomon So, et al.. (2010). Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nature Medicine. 16(2). 205–213. 276 indexed citations
16.
So, Lomon, et al.. (1989). A lipid-associated sulfated proteoglycan from Nereis coelomic fluid is a hemagglutinin. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 93(4). 859–865. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026